These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4452560)

  • 21. Effects of 5-bromodeoxyuridine on tumorigenicity, immunogenicity, virus production, plasminogen activator, and melanogenesis of mouse melanoma cells.
    Silagi S
    Int Rev Cytol; 1976; 45():65-111. PubMed ID: 821894
    [No Abstract]   [Full Text] [Related]  

  • 22. Oncogenic viruses in the thrombocytopenic stage of experimental HIPA-plasmacytoma.
    Pedio G; Rüttner JR; Odermatt B; Gut D
    Experientia; 1974 Mar; 30(3):289-91. PubMed ID: 4363226
    [No Abstract]   [Full Text] [Related]  

  • 23. Some effects of 5-bromodeoxyuridine on polyoma-transformed mouse cells.
    Grady LJ; North AB
    Exp Cell Res; 1974 Jul; 87(1):120-6. PubMed ID: 4366852
    [No Abstract]   [Full Text] [Related]  

  • 24. On plasmocytoma--oncognesis of mice. Evolution of a poorly differentiated sarcoma (HIPA tumor of BALB-c mice) into a plasmocytoma. iv. A comparative histological and electron microscopic study.
    Pedio G; Grieshaber E; Rüttner JR
    Pathol Microbiol (Basel); 1969; 34(2):65-85. PubMed ID: 5379706
    [No Abstract]   [Full Text] [Related]  

  • 25. Polyadenylation of 35S RNA in vitro by a cytoplasmic particulate fraction from mouse myeloma.
    Wong-Staal F; Saxinger WC; Gallo RC; Gillespie DH
    Biochem Biophys Res Commun; 1976 Apr; 69(3):599-607. PubMed ID: 1267806
    [No Abstract]   [Full Text] [Related]  

  • 26. Type C virus particles in X63-Ag8.653 mouse plasmacytoma cells and in hybridomas derived from it.
    Rudolph M; Karsten U; Micheel B
    Arch Geschwulstforsch; 1983; 53(6):513-9. PubMed ID: 6670912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue culture studies of mouse mammary tumor cells and associated viruses.
    Owens RB; Hackett AJ
    J Natl Cancer Inst; 1972 Nov; 49(5):1321-32. PubMed ID: 4346536
    [No Abstract]   [Full Text] [Related]  

  • 28. Isolation and characterization of a cell line from the cocultivation of Lucké renal tumor cells and nontransformed feeder cells.
    Kucera LS; Simonson J
    J Natl Cancer Inst; 1974 Aug; 53(2):415-21. PubMed ID: 4367239
    [No Abstract]   [Full Text] [Related]  

  • 29. Properties of 5-bromodeoxyuridine-resistant lines of higher plant cells in liquid culture.
    Ohyama K
    Exp Cell Res; 1974 Nov; 89(1):31-8. PubMed ID: 4279827
    [No Abstract]   [Full Text] [Related]  

  • 30. Giemsa-banded chromosomes of mouse myeloma in relationship to oncogenicity.
    Shepard JS; Wurster-Hill DH; Pettengill OS; Sorenson GD
    Cytogenet Cell Genet; 1974; 13(3):279-309. PubMed ID: 4135357
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on virus induction by 5-bromodeoxyuridine in nonproducer murine sarcoma virus-transformed 3T3 cells.
    Margalith M; Thornton H; Narconis R; Pinkerton H; Green M
    Virology; 1975 May; 65(1):27-39. PubMed ID: 49978
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of 5-bromodeoxyuridine (BrdU) on cardiac muscle differentiation.
    Chacko S; Joseph X
    Dev Biol; 1974 Oct; 40(2):340-54. PubMed ID: 4609820
    [No Abstract]   [Full Text] [Related]  

  • 33. [Instability of phenotypes of tumor cells--on decarcinogenesis].
    Hozumi M
    Tanpakushitsu Kakusan Koso; 1971 Aug; 16(8):599-612. PubMed ID: 4934857
    [No Abstract]   [Full Text] [Related]  

  • 34. Bromodeoxyuridine (BUdR) treatment of melanoma cells decreases cellular proteolytic activity.
    Evans I; Bosmann HB
    Exp Cell Res; 1977 Aug; 108(1):151-5. PubMed ID: 19270
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies of nitrogen mustard transport by mouse myeloma and hemopoietic precursor cells.
    Ogawa M; Bergsagel DE; McCulloch EA
    Cancer Res; 1973 Dec; 33(12):3172-5. PubMed ID: 4760532
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of 5-bromodeoxyuridine on interferon production in human cells.
    Baker PN; Bradshaw TK; Morser J; Burke DC
    J Gen Virol; 1979 Oct; 45(1):177-84. PubMed ID: 160442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumorigenicity and intracisternal A-particle expression of hybrids between murine myeloma and lymphocytes.
    Giacomoni D
    Cancer Res; 1979 Nov; 39(11):4481-4. PubMed ID: 498079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electron microscope observations on virus particles associated with a transplantable renal adenocarcinoma in BALB-cf-Cd mice.
    Felluga B; Claude A; Mrena E
    J Natl Cancer Inst; 1969 Aug; 43(2):319-33. PubMed ID: 5797837
    [No Abstract]   [Full Text] [Related]  

  • 39. 5-Bromodeoxyuridine-tolerant melanoma cells in vitro and in vivo.
    Pasztor LM; Hu F; McNulty WP
    Yale J Biol Med; 1973 Dec; 46(5):397-410. PubMed ID: 4544338
    [No Abstract]   [Full Text] [Related]  

  • 40. Rous sarcoma virus-transformed hamster tumor cells resistant to 5-bromodeoxyuridine.
    Kuwata T; Morinaga N; Okazaki T; Ishitani R
    J Natl Cancer Inst; 1974 Jun; 52(6):1763-70. PubMed ID: 4365677
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.